Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-01-03 Sale |
2023-01-05 6:03 pm |
89bio Inc. | ETNB | Martins Ryan Chief Financial Officer |
5,947 | $12.51 | $74,397 | 36,368 (Direct) |
View |
| 2022-10-18 Purchase |
2022-10-20 5:28 pm |
89bio Inc. | ETNB | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
1,172,741 | $7.65 | $8,971,469 | 8,955,410 (Indirect) |
View |
| 2022-07-01 Purchase |
2022-07-06 5:27 pm |
89bio Inc. | ETNB | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
2,816,900 | $3.55 | $9,999,995 | 9,191,119 (Indirect) |
View |
| 2022-02-01 Sale |
2022-02-03 4:30 pm |
89bio Inc. | ETNB | Waisbourd Ram See Remarks |
7,000 | $5.7 | $39,900 | 17,309 (Direct) |
View |
| 2022-01-27 Purchase |
2022-01-31 4:30 pm |
89bio Inc. | ETNB | PALEKAR ROHAN Chief Executive Officer |
7,500 | $7.0467 | $52,850 | 45,845 (Direct) |
View |
| 2022-01-25 Sale |
2022-01-27 5:22 pm |
89bio Inc. | ETNB | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Advisors Israel II Ltd OrbiMed Israel GP II L.P. 10% Owner |
70,573 | $8.3939 | $592,384 | 1,829,436 (Indirect) |
View |
| 2021-12-16 Sale |
2021-12-20 4:30 pm |
89bio Inc. | ETNB | Waisbourd Ram See Remarks |
7,000 | $11.48 | $80,360 | 6,106 (Direct) |
View |
| 2021-11-16 Sale |
2021-11-18 6:37 pm |
89bio Inc. | ETNB | Waisbourd Ram See Remarks |
7,000 | $16.49 | $115,430 | 18,203 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-02-01 Tax Withholding |
2023-02-03 5:10 pm |
N/A N/A |
89bio Inc. | ETNB | Martins Ryan Chief Financial Officer |
408 | $12.05 | 35,960 (Direct) |
View |
| 2023-02-01 Tax Withholding |
2023-02-03 5:10 pm |
N/A N/A |
89bio Inc. | ETNB | Mansbach Harry H Chief Medical Officer |
680 | $12.05 | 68,158 (Direct) |
View |
| 2023-02-01 Tax Withholding |
2023-02-03 5:08 pm |
N/A N/A |
89bio Inc. | ETNB | Le-Nguyen Quoc See Remarks |
695 | $12.05 | 64,709 (Direct) |
View |
| 2022-11-15 Tax Withholding |
2022-12-13 5:52 pm |
N/A N/A |
89bio Inc. | ETNB | Mansbach Harry H Chief Medical Officer |
3,113 | $9.79 | 68,838 (Direct) |
View |
| 2022-11-15 Option Award |
2022-12-13 5:52 pm |
N/A N/A |
89bio Inc. | ETNB | Mansbach Harry H Chief Medical Officer |
9,000 | $0 | 68,838 (Direct) |
View |
| 2022-09-28 Tax Withholding |
2022-09-30 7:06 pm |
N/A N/A |
89bio Inc. | ETNB | Le-Nguyen Quoc See Remarks |
2,882 | $5.76 | 65,404 (Direct) |
View |
| 2022-09-28 Option Award |
2022-09-30 7:06 pm |
N/A N/A |
89bio Inc. | ETNB | Le-Nguyen Quoc See Remarks |
12,083 | $0 | 65,404 (Direct) |
View |
| 2022-09-30 Tax Withholding |
2022-09-30 7:06 pm |
N/A N/A |
89bio Inc. | ETNB | Le-Nguyen Quoc See Remarks |
1,297 | $5.79 | 65,404 (Direct) |
View |
| 2022-09-28 Tax Withholding |
2022-09-30 7:05 pm |
N/A N/A |
89bio Inc. | ETNB | Martins Ryan Chief Financial Officer |
2,018 | $5.76 | 42,315 (Direct) |
View |
| 2022-09-28 Option Award |
2022-09-30 7:05 pm |
N/A N/A |
89bio Inc. | ETNB | Martins Ryan Chief Financial Officer |
5,833 | $0 | 42,315 (Direct) |
View |
| 2022-09-28 Tax Withholding |
2022-09-30 7:04 pm |
N/A N/A |
89bio Inc. | ETNB | Mansbach Harry H Chief Medical Officer |
2,882 | $5.76 | 62,951 (Direct) |
View |
| 2022-09-28 Option Award |
2022-09-30 7:04 pm |
N/A N/A |
89bio Inc. | ETNB | Mansbach Harry H Chief Medical Officer |
8,333 | $0 | 62,951 (Direct) |
View |
| 2022-09-28 Tax Withholding |
2022-09-30 7:02 pm |
N/A N/A |
89bio Inc. | ETNB | PALEKAR ROHAN Chief Executive Officer |
11,527 | $5.76 | 219,429 (Direct) |
View |
| 2022-09-28 Option Award |
2022-09-30 7:02 pm |
N/A N/A |
89bio Inc. | ETNB | PALEKAR ROHAN Chief Executive Officer |
33,333 | $0 | 219,429 (Direct) |
View |
| 2022-09-09 Option Award |
2022-09-13 7:29 pm |
N/A N/A |
89bio Inc. | ETNB | Mansbach Harry H Chief Medical Officer |
25,000 | $0 | 57,500 (Direct) |
View |
| 2022-09-09 Option Award |
2022-09-13 7:20 pm |
N/A N/A |
89bio Inc. | ETNB | Martins Ryan Chief Financial Officer |
15,000 | $0 | 38,500 (Direct) |
View |
| 2022-09-09 Option Award |
2022-09-13 7:16 pm |
N/A N/A |
89bio Inc. | ETNB | Le-Nguyen Quoc See Remarks |
25,000 | $0 | 57,500 (Direct) |
View |
| 2022-09-08 Exercise |
2022-09-09 4:39 pm |
N/A 2028-11-09 |
89bio Inc. | ETNB | PALEKAR ROHAN Chief Executive Officer |
100,000 | $0 | 422,854 (Direct) |
View |
| 2022-09-08 Exercise |
2022-09-09 4:39 pm |
N/A N/A |
89bio Inc. | ETNB | PALEKAR ROHAN Chief Executive Officer |
100,000 | $1.93 | 422,854 (Direct) |
View |
| 2022-05-16 Option Award |
2022-06-02 4:30 pm |
N/A 2032-05-16 |
89bio Inc. | ETNB | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
25,000 | $0 | 25,000 (Indirect) |
View |
| 2022-05-25 Option Award |
2022-05-27 4:15 pm |
N/A 2032-05-25 |
89bio Inc. | ETNB | Atkinson Edward Morrow III Director |
6,250 | $0 | 6,250 (Direct) |
View |
| 2022-05-16 Option Award |
2022-05-18 4:12 pm |
N/A 2032-05-16 |
89bio Inc. | ETNB | Hayden Michael R Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-05-16 Option Award |
2022-05-18 4:09 pm |
N/A 2032-05-16 |
89bio Inc. | ETNB | DiRocco Derek Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-05-16 Option Award |
2022-05-18 4:06 pm |
N/A 2032-05-16 |
89bio Inc. | ETNB | Zoth Lota S. Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-05-16 Option Award |
2022-05-18 4:06 pm |
N/A 2032-05-16 |
89bio Inc. | ETNB | LAPORTE KATHLEEN Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-05-16 Option Award |
2022-05-18 4:05 pm |
N/A 2032-05-16 |
89bio Inc. | ETNB | Grunberg Gregory Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-05-16 Option Award |
2022-05-18 4:05 pm |
N/A 2032-05-16 |
89bio Inc. | ETNB | Altschuler Steven Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-02-05 Tax Withholding |
2022-04-13 4:05 pm |
N/A N/A |
89bio Inc. | ETNB | Mansbach Harry H Chief Medical Officer |
1,363 | $5.23 | 31,137 (Direct) |
View |
| 2022-02-05 Tax Withholding |
2022-04-13 4:05 pm |
N/A N/A |
89bio Inc. | ETNB | Martins Ryan Chief Financial Officer |
1,022 | $5.23 | 22,478 (Direct) |
View |
| 2022-02-05 Tax Withholding |
2022-04-13 4:05 pm |
N/A N/A |
89bio Inc. | ETNB | PALEKAR ROHAN Chief Executive Officer |
4,088 | $5.23 | 95,957 (Direct) |
View |
| 2022-02-05 Tax Withholding |
2022-04-13 4:05 pm |
N/A N/A |
89bio Inc. | ETNB | Le-Nguyen Quoc See Remarks |
1,363 | $5.23 | 31,137 (Direct) |
View |
Ownership |
2022-03-01 6:39 pm |
N/A 2032-02-16 |
89bio Inc. | ETNB | Atkinson Edward Morrow III Director |
0 | $0 | 30,000 (Direct) |
View |
| 2022-02-17 Option Award |
2022-02-22 5:13 pm |
N/A 2032-02-16 |
89bio Inc. | ETNB | Waisbourd Ram See Remarks |
33,750 | $0 | 33,750 (Direct) |
View |
| 2022-02-17 Option Award |
2022-02-22 5:11 pm |
N/A 2032-02-16 |
89bio Inc. | ETNB | Martins Ryan Chief Financial Officer |
68,000 | $0 | 75,500 (Direct) |
View |
| 2022-02-17 Option Award |
2022-02-22 5:11 pm |
N/A 2032-02-16 |
89bio Inc. | ETNB | Le-Nguyen Quoc See Remarks |
92,500 | $0 | 102,500 (Direct) |
View |
| 2022-02-17 Option Award |
2022-02-22 5:09 pm |
N/A 2032-02-16 |
89bio Inc. | ETNB | Mansbach Harry H Chief Medical Officer |
92,500 | $0 | 102,500 (Direct) |
View |
| 2022-02-17 Option Award |
2022-02-22 5:06 pm |
N/A 2032-02-16 |
89bio Inc. | ETNB | PALEKAR ROHAN Chief Executive Officer |
274,200 | $0 | 320,045 (Direct) |
View |
| 2022-02-01 Exercise |
2022-02-03 4:30 pm |
N/A 2028-11-09 |
89bio Inc. | ETNB | Waisbourd Ram See Remarks |
7,000 | $0 | 17,309 (Direct) |
View |
| 2022-02-01 Exercise |
2022-02-03 4:30 pm |
N/A N/A |
89bio Inc. | ETNB | Waisbourd Ram See Remarks |
7,000 | $1.93 | 17,309 (Direct) |
View |
| 2021-12-16 Exercise |
2021-12-20 4:30 pm |
N/A 2029-10-01 |
89bio Inc. | ETNB | Waisbourd Ram See Remarks |
7,000 | $0 | 6,106 (Direct) |
View |
| 2021-12-16 Exercise |
2021-12-20 4:30 pm |
N/A N/A |
89bio Inc. | ETNB | Waisbourd Ram See Remarks |
7,000 | $1.93 | 6,106 (Direct) |
View |
| 2021-11-16 Exercise |
2021-11-18 6:37 pm |
N/A 2028-11-09 |
89bio Inc. | ETNB | Waisbourd Ram See Remarks |
7,000 | $0 | 18,203 (Direct) |
View |
| 2021-11-16 Exercise |
2021-11-18 6:37 pm |
N/A N/A |
89bio Inc. | ETNB | Waisbourd Ram See Remarks |
7,000 | $1.93 | 18,203 (Direct) |
View |
| 2021-11-01 Option Award |
2021-11-03 4:36 pm |
N/A 2031-11-01 |
89bio Inc. | ETNB | LAPORTE KATHLEEN Director |
25,000 | $0 | 25,000 (Direct) |
View |